347 related articles for article (PubMed ID: 22281731)
1. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
[TBL] [Abstract][Full Text] [Related]
2. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
3. Partial-volume model for determining white matter and gray matter cerebral blood volume for analysis of gliomas.
Lee MC; Cha S; Chang SM; Nelson SJ
J Magn Reson Imaging; 2006 Mar; 23(3):257-66. PubMed ID: 16456821
[TBL] [Abstract][Full Text] [Related]
4. Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion.
Knutsson L; Lindgren E; Ahlgren A; van Osch MJ; Bloch KM; Surova Y; Ståhlberg F; van Westen D; Wirestam R
Magn Reson Med; 2014 Oct; 72(4):996-1006. PubMed ID: 24285621
[TBL] [Abstract][Full Text] [Related]
5. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps.
Emblem KE; Nedregaard B; Nome T; Due-Tonnessen P; Hald JK; Scheie D; Borota OC; Cvancarova M; Bjornerud A
Radiology; 2008 Jun; 247(3):808-17. PubMed ID: 18487536
[TBL] [Abstract][Full Text] [Related]
6. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
7. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach.
Wirestam R; Knutsson L; Risberg J; Börjesson S; Larsson EM; Gustafson L; Passant U; Ståhlberg F
Acta Radiol; 2007 Jun; 48(5):550-6. PubMed ID: 17520432
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of advanced MRI in differentiating high-grade from low-grade gliomas in a setting of routine service.
Chawalparit O; Sangruchi T; Witthiwej T; Sathornsumetee S; Tritrakarn S; Piyapittayanan S; Chaicharoen P; Direksunthorn T; Charnchaowanish P
J Med Assoc Thai; 2013 Oct; 96(10):1365-73. PubMed ID: 24350420
[TBL] [Abstract][Full Text] [Related]
9. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
Ingrisch M; Sourbron S; Morhard D; Ertl-Wagner B; Kümpfel T; Hohlfeld R; Reiser M; Glaser C
Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532
[TBL] [Abstract][Full Text] [Related]
10. Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.
Alcaide-Leon P; Pareto D; Martinez-Saez E; Auger C; Bharatha A; Rovira A
AJNR Am J Neuroradiol; 2015 May; 36(5):871-6. PubMed ID: 25634715
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
12. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
Young R; Babb J; Law M; Pollack E; Johnson G
J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
[TBL] [Abstract][Full Text] [Related]
13. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.
Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC
AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064
[TBL] [Abstract][Full Text] [Related]
14. Correlation between dynamic contrast-enhanced perfusion MRI relative cerebral blood volume and vascular endothelial growth factor expression in meningiomas.
Ginat DT; Mangla R; Yeaney G; Schaefer PW; Wang H
Acad Radiol; 2012 Aug; 19(8):986-90. PubMed ID: 22591719
[TBL] [Abstract][Full Text] [Related]
15. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
[TBL] [Abstract][Full Text] [Related]
16. Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRI.
Newman GC; Hospod FE; Patlak CS; Fain SE; Pulfer KA; Cook TD; O'Sullivan F
J Cereb Blood Flow Metab; 2006 Jun; 26(6):760-70. PubMed ID: 16319833
[TBL] [Abstract][Full Text] [Related]
17. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.
White CM; Pope WB; Zaw T; Qiao J; Naeini KM; Lai A; Nghiemphu PL; Wang JJ; Cloughesy TF; Ellingson BM
J Neuroimaging; 2014; 24(1):23-30. PubMed ID: 22672084
[TBL] [Abstract][Full Text] [Related]
18. Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.
Leu K; Enzmann DR; Woodworth DC; Harris RJ; Tran AN; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
Cancer Imaging; 2014 Nov; 14(1):31. PubMed ID: 25608485
[TBL] [Abstract][Full Text] [Related]
19. MR evaluation of vessel size imaging of human gliomas: Validation by histopathology.
Kellner E; Breyer T; Gall P; Müller K; Trippel M; Staszewski O; Stein F; Saborowski O; Dyakova O; Urbach H; Kiselev VG; Mader I
J Magn Reson Imaging; 2015 Oct; 42(4):1117-25. PubMed ID: 25683112
[TBL] [Abstract][Full Text] [Related]
20. Human cerebral blood volume measurements using dynamic contrast enhancement in comparison to dynamic susceptibility contrast MRI.
Artzi M; Liberman G; Nadav G; Vitinshtein F; Blumenthal DT; Bokstein F; Aizenstein O; Ben Bashat D
Neuroradiology; 2015 Jul; 57(7):671-8. PubMed ID: 25845809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
